Arkolith/Insider Trading/ARQT/Form 4

Gilbert Halley E

DirectorArcutis Biotherapeutics, Inc. (ARQT) · full profile →Form 4 · filed Nov 21, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$455K
Net Open-Market Flow
-$455K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 20, 2025Sell(S)17K$27.55$455K22K
Nov 20, 2025Option exercise(M)12K$7.51$92K39K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 20, 2025Option exercise(M)12K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001601360-25-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML